Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity
nutrients Article Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study Antonella Mirizzi 1 , Isabella Franco 1 , Carla Maria Leone 1 , Caterina Bonfiglio 1 , Raffaele Cozzolongo 2, Maria Notarnicola 3, Vito Giannuzzi 2, Valeria Tutino 3, Valentina De Nunzio 3, Irene Bruno 1 , Claudia Buongiorno 1 , Angelo Campanella 1 , Valentina Deflorio 1, Annamaria Pascale 1, Filippo Procino 1, Paolo Sorino 1 and Alberto Rubén Osella 1,* 1 Laboratory of Epidemiology and Biostatistics, National Institute of Gastroenterology, “S. de Bellis” Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy; antonella.mirizzi@irccsdebellis.it (A.M.); isabella.franco@irccsdebellis.it (I.F.); carlaleone@interfree.it (C.M.L.); catia.bonfiglio@irccsdebellis.it (C.B.); irenebrunodiet@gmail.com (I.B.); buongiorno.claudia@gmail.com (C.B.); angelocampanella7@gmail.com (A.C.); valentinadeflorio@yahoo.it (V.D.); annamariapsc@hotmail.com (A.P.); filippo.procino@irccsdebellis.it (F.P.); paolosorino96@libero.it (P.S.) 2 Clinic Gastroenterologic Unit, National Institute of Gastroenterology, “S. de Bellis” Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy; raffaele.cozzolongo@irccsdebellis.it (R.C.); vito.giannuzzi@irccsdebellis.it (V.G.) 3 Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology, “S. de Bellis” Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy; maria.notarnicola@irccsdebellis.it (M.N.); valeria.tutino@irccsdebellis.it (V.T.); valentinadx@hotmail.it (V.D.N.) * Correspondence: arosella@irccsdebellis.it; Tel.: +39-08-0499-4655 Received: 29 October 2019; Accepted: 5 November 2019; Published: 12 November 2019 Abstract: Background: The high prevalence of non-alcoholic fatty liver disease (NAFLD) observed in Western countries is due to the concurrent epidemics of overweight/obesity and associated metabolic complications, both recognized risk factors.
[Show full text]